US6997918B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Methods and devices for obstructing and aspirating lung tissue segments

Assignee: Pulmonx Corp

•

Filing: 2003-03-04

•

Granted: 2006-02-14

•

Expires: 2023-03-04

📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port. Or, providing the port with a valve which allows outflow of gas from the isolated lung tissue segment during expiration of the respiratory cycle but prevents inflow of air during inspiration. In addition, a number of other methods may be used. The obstructive device may remain as an implant, to maintain isolation and optionally allow subsequent aspiration, or the device may be removed at any time.

Inventors

👤 Peter P. Soltesz
👤 Robert Kotmel
👤 Tony Wondka
👤 Michael P. Reilly
👤 Wally S. Buch

Bibliographic Details

Application Number —

Jurisdiction US

Data Source google_patents

Last Synchronized 2026-10-24 23:15

CPC Classifications

A; A61; A61B; A61B17/00; A61B17/12; A61B17/12022; A61B17/12131; A61B17/12168; A61B17/12172; A61B17/12099; A61B17/12104; A61B17/12136; A61B17/12159; A61B17/12181; A61B17/1219; A61B2017/1205; A61B17/22; A61B2017/22051; A61B2017/22065; A61B2017/22067; A61B2017/22068

Claims Analysis

Total Claims: 17

Claim 1

Independent Claim 87 words

A method for lung volume reduction, said method comprising: deploying an obstructive device in a lung passageway to a lung tissue segment; passing an access tube through the obstructive device; aspirating the segment through the access tube through the deployed obstructive device to at least partially collapse the lung segment, wherein the obstructive device is left in place as an implant after aspiration is complete, wherein the aspirating comprises coupling an aspiration catheter to the access tube and aspirating gas through the catheter from the lung segment.

Claim 2

Independent Claim 87 words

Claim 3

Dependent Claim 25 words

A method as in claim 1 , wherein the obstructive device comprises a self-sealing septum and passing comprises piercing the access tube through the septum.

Claim 4

Dependent Claim 18 words

A method as in claim 2 , wherein the septum comprises a solid membrane or a pre-cut membrane.

Claim 5

Dependent Claim 59 words

A method as in claim 1 , wherein aspirating comprises: advancing an aspiration catheter into the lung passageway toward the obstructive device, wherein the aspiration catheter has an occlusion balloon near its distal end; inflating the occlusion balloon to substantially occlude the lung passageway proximal to the obstructive device; and aspirating gas through the access tube and the catheter.

Claim 6

Dependent Claim 29 words

A method as in claim 1 , wherein the obstructive device comprises a structural support and deploying comprises expanding the structural support so that it anchors in the passageway.

Claim 7

Dependent Claim 34 words

A method as in claim 5 , wherein the structural support comprises a self-expanding support and expanding comprises releasing the self-expanding support from constraint so that it expands and thereby anchors in the passageway.

Claim 8

Dependent Claim 19 words

A method as in claim 6 , wherein deploying further comprises inflating a balloon which expands the structural support.

Claim 9

Dependent Claim 41 words

A method as in claim 1 , further comprising positioning an access catheter in the lung passageway prior to deployment of the obstructive device, said access catheter having a proximal end, a distal end, and at least one lumen extending therethrough.

Claim 10

Dependent Claim 47 words

A method as in claim 8 , wherein the access catheter has an occlusion balloon near its distal end and aspirating comprises: inflating the occlusion balloon to substantially occlude the lung passageway proximal to the obstructive device; and aspirating gas through the access tube and the catheter.

Claim 11

Dependent Claim 14 words

A method as in claim 9 , wherein the access catheter provides optical imaging.

Claim 12

Dependent Claim 13 words

A method as in claim 9 , wherein the access catheter is steerable.

Claim 13

Dependent Claim 19 words

A method as in claim 9 , wherein the access catheter is positioned with the use of a guidewire.

Claim 14

Dependent Claim 13 words

A method as in claim 12 , wherein the guidewire provides imaging capabilities.

Claim 15

Dependent Claim 20 words

A method as in claim 1 , further comprising introducing a gas or liquid to the segment prior to aspiration.

Claim 16

Dependent Claim 22 words

A method as in claim 14 , wherein the gas comprises 100% oxygen, a Helium-Oxygen mixture or a low molecular weight gas.

Claim 17

Dependent Claim 15 words

A method as in claim 14 , wherein the liquid comprises perfluorocarbon or a drug.

References Cited (Backward Citations)

US3162190A Cited

US3322126A Cited

US3498286A Cited

US3542026A Cited

US3669098A Cited

US3677262A Cited

US3776222A Cited

US3866599A Cited

US3913568A Cited

US4041936A Cited

US4148307A Cited

US4086919A Cited

US4327721A Cited

US4327720A Cited

US4453545A Cited

US4468216A Cited

US4567882A Cited

US4819664A Cited

US4896941A Cited

US4716896A Cited

US4784133A Cited

US4976710A Cited

US4961738A Cited

US4742819A Cited

US4862874A Cited

US4886496A Cited

US4846153A Cited

US4850371A Cited

US4958932A Cited

US4913701A Cited

US5039461A Cited

US4949716A Cited

WO1990006086A1 Cited

US4955375A Cited

US5707352A Cited

US5309903A Cited

US5146916A Cited

US5056529A Cited

US5143062A Cited

WO1992010971A1 Cited

US5285778A Cited

US5331947A Cited

US5361753A Cited

US5400771A Cited

US5607386A Cited

US5499625A Cited

US5645519A Cited

US5840064A Cited

US5478319A Cited

WO1995033506A1 Cited

US5642730A Cited

US5477851A Cited

US5598840A Cited

WO1996032153A1 Cited

US5660175A Cited

US5830222A Cited

US5653231A Cited

US5752921A Cited

US5904648A Cited

US5682880A Cited

WO1998044854A1 Cited

US6083255A Cited

US5972026A Cited

WO1998049191A1 Cited

WO1998048706A1 Cited

US5957949A Cited

US5957919A Cited

WO1999001076A1 Cited

US5954636A Cited

WO1999023955A1 Cited

WO1999032040A1 Cited

WO1999034741A1 Cited

US5925060A Cited

US6493589B1 Cited

US6174323B1 Cited

WO1999064109A1 Cited

WO2000051510A1 Cited

WO2000062699A2 Cited

WO2001002402A1 Cited

US6287290B1 Cited

WO2001003642A1 Cited

WO2001010314A2 Cited

WO2001013908A2 Cited

US20010051799A1 Cited

EP1078601A2 Cited

WO2001013839A1 Cited

US6258100B1 Cited

US6679264B1 Cited

US20040016435A1 Cited

US20030228344A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage	Window Opens	Payment Deadline	Surcharge Period Until	Estimated Fee	Status
3.5 Years (Year 4)	2009-02-13	2009-08-15	2010-02-14	$2000.00	Window Closed / Lapsed
7.5 Years (Year 8)	2013-02-13	2013-08-15	2014-02-14	$3760.00	Window Closed / Lapsed
11.5 Years (Year 12)	2017-02-13	2017-08-15	2018-02-14	$7700.00	Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag

Select Category

Notes (Optional)